Page last updated: 2024-11-04

sulfasalazine and Bone Hypertrophy

sulfasalazine has been researched along with Bone Hypertrophy in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collange, C1
Brantus, JF1
Sidot, C1
Meunier, PJ1

Other Studies

1 other study available for sulfasalazine and Bone Hypertrophy

ArticleYear
Sapho syndrome with femoral hyperostosis. Two case-reports.
    Revue du rhumatisme (English ed.), 1996, Volume: 63, Issue:5

    Topics: Adult; Antirheumatic Agents; Diphosphonates; Female; Femur; Humans; Hyperostosis; Magnetic Resonance

1996